Ryan D Maynard Insider Trading $RIGL RIGEL PHARMACEUTICALS INC
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Ryan D Maynard.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Ryan D Maynard. Ryan D Maynard is EVP & CFO in RIGEL PHARMACEUTICALS INC ($RIGL) and VP Finance, Acting CFO in RIGEL PHARMACEUTICALS INC ($RIGL) and Director in Lion Biotechnologies, Inc. ($LBIO).
Ryan D Maynard in RIGEL PHARMACEUTICALS INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Ryan D Maynard: EVP & CFO, VP Finance, Acting CFO
Holdings: 100,000 shares
Current Value: $245,000
Latest Transaction: Nov 07 2017
$RIGL Market Capitalization: $237.45M
$RIGL Previous Close: $2.45
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Ryan D Maynard in RIGEL PHARMACEUTICALS INC
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov 07 2017 | RIGL | RIGEL PHARMACEUTIC ... | Maynard Ryan D | EVP & CFO | Option Exercise | M | 2.14 | 100,000 | 214,000 | 75,000 | |
| Nov 07 2017 | RIGL | RIGEL PHARMACEUTIC ... | Maynard Ryan D | EVP & CFO | Sell | S | 3.90 | 100,000 | 390,000 | 0 | 100 K to 0 (-100.00 %) |
| Nov 07 2017 | RIGL | RIGEL PHARMACEUTIC ... | Maynard Ryan D | EVP & CFO | Buy | M | 2.14 | 100,000 | 214,000 | 100,000 | 0 to 100 K |
| Apr 21 2017 | RIGL | RIGEL PHARMACEUTIC ... | Maynard Ryan D | EVP & CFO | Option Exercise | A | 2.74 | 150,000 | 411,000 | 150,000 | |
| Apr 21 2017 | RIGL | RIGEL PHARMACEUTIC ... | Maynard Ryan D | EVP & CFO | Option Exercise | A | 3.59 | 62,500 | 224,375 | 62,500 | |
| Feb 06 2017 | RIGL | RIGEL PHARMACEUTIC ... | Maynard Ryan D | EVP & CFO | Option Exercise | A | 2.11 | 150,000 | 316,500 | 150,000 | |
| Apr 06 2016 | RIGL | RIGEL PHARMACEUTIC ... | Maynard Ryan D | EVP & CFO | Option Exercise | A | 2.14 | 175,000 | 374,500 | 175,000 | |
| Apr 06 2016 | RIGL | RIGEL PHARMACEUTIC ... | Maynard Ryan D | EVP & CFO | Option Exercise | A | 3.59 | 62,500 | 224,375 | 62,500 | |
| Jan 28 2016 | RIGL | RIGEL PHARMACEUTIC ... | Maynard Ryan D | EVP & CFO | Option Exercise | A | 2.74 | 150,000 | 411,000 | 150,000 | |
| Aug 08 2006 | RIGL | RIGEL PHARMACEUTIC ... | Maynard Ryan D | VP Finance, Acting ... | Option Exercise | A | 9.56 | 1,000 | 9,560 | 1,000 |
Page: 1